Perimeter Medical Imaging AI Submits FDA Application for Advanced Imaging System

Perimeter Medical Imaging AI ( (TSE:PINK) ) just unveiled an announcement.

Perimeter Medical Imaging AI has submitted a Premarket Approval application to the FDA for its B-Series OCT system with ImgAssist AI 2.0, aimed at improving outcomes in breast-conserving surgeries. The pivotal trial showed significant results in reducing residual cancer during surgery, suggesting potential widespread adoption among breast cancer surgeons if approved, marking a significant milestone for the company’s operations and industry positioning.

More about Perimeter Medical Imaging AI

Perimeter Medical Imaging AI, Inc., based in Toronto, Canada and Dallas, Texas, is a medical technology company focused on transforming cancer surgery through advanced imaging tools. The company offers the FDA-cleared Perimeter S-Series OCT system for real-time visualization of excised tissues and is developing the next-generation Perimeter B-Series OCT with ImgAssist AI, supported by a significant grant from the Cancer Prevention and Research Institute of Texas.

YTD Price Performance: 13.33%

Average Trading Volume: 81,302

Technical Sentiment Consensus Rating: Buy

Current Market Cap: C$45.14M

For an in-depth examination of PINK stock, go to TipRanks’ Stock Analysis page.